Considering positive ANA titers only, both DCR and ORR did not significantly differ in NSCLC (p = 0.189 and 0.438), renal cell carcinoma (p = 0.898 and 0.898) and bladder cancer (p = 0.809 and 0.350). Here, BTG3 is linked to hereditary clear cell renal cell carcinoma.